Study of KHK 4323 in Healthy Volunteers and Subjects With Atopic Dermatitis

NCT03846466 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Stopped The study terminated for safety reasons.

Conditions

Atopic Dermatitis

Interventions

DRUG: KHK4323 IV/S
DRUG: KHK4323 SC/S
DRUG: KHK4323 IV/M
DRUG: Placebo IV/S
DRUG: Placebo IV/M
DRUG: Placebo SC/S

Sponsor

Kyowa Kirin Co., Ltd.